Comparing the Diagnostic Accuracy of the Probe-to-Bone Test, Plain Radiography, and Serum Biomarkers in Detecting Diabetic Foot Osteomyelitis. [PDF]
Herrera-Casamayor M +5 more
europepmc +1 more source
Remote Monitoring in Myasthenia Gravis: Exploring Symptom Variability
ABSTRACT Background Myasthenia gravis (MG) is a rare, autoimmune disorder characterized by fluctuating muscle weakness and potential life‐threatening crises. While continuous specialized care is essential, access barriers often delay timely interventions. To address this, we developed MyaLink, a telemedical platform for MG patients.
Maike Stein +13 more
wiley +1 more source
Validation of on-slide immunocytochemistry controls prepared from long-term preserved prefixed cell suspensions. [PDF]
Roque RR +6 more
europepmc +1 more source
Neuropsychiatric Symptoms Mimicking Dementia in a Patient Treated With Imatinib
ABSTRACT Tyrosine kinase inhibitors are the cornerstone of chronic myeloid leukemia treatment. Newer agents have more potency and a broader spectrum of action, but also a higher potential for neuropsychiatric side effects. We present a case of a patient on imatinib who developed progressive cognitive, mood, and behavioral alterations.
Ashley Jones +3 more
wiley +1 more source
Why study design matters: evaluating bias and generalizability in contrast-enhanced mammography research. [PDF]
Lobbes MBI, Nelemans PJ.
europepmc +1 more source
Real‐World Performance of CSF Kappa Free Light Chains in the 2024 McDonald Criteria
ABSTRACT Objective Kappa free light chains (KFLCs) in the cerebrospinal fluid (CSF) have a similar performance to CSF‐restricted oligoclonal bands (OCB) for multiple sclerosis (MS) diagnosis. To help with implementation, we set out to resolve several remaining uncertainties: (1) performance in a real‐world cohort and the 2024 McDonald criteria; (2 ...
Maya M. Leibowitz +11 more
wiley +1 more source
Implementation of noninvasive liver disease screening tools in primary care. [PDF]
Nowak K +6 more
europepmc +1 more source
Applying an Ethical Lens to the Treatment of People With Multiple Sclerosis
ABSTRACT The practice of neurology requires an understanding of clinical ethics for decision‐making. In multiple sclerosis (MS) care, there are a wide range of ethical considerations that may arise. These involve shared decision‐making around selection of a disease‐modifying therapy (DMT), risks and benefits of well‐studied medications in comparison to
Methma Udawatta, Farrah J. Mateen
wiley +1 more source
Clinical utility of lung diffusing capacity for carbon monoxide (DLco) in children: a retrospective single-center study. [PDF]
Micic S, Vogt A, Moeller A, Seidl E.
europepmc +1 more source
Malaria rapid diagnostic tests in endemic settings.
J. Maltha +3 more
semanticscholar +1 more source

